Sleep Disorders Trial, Recruiting NCT06567210 Sponsor: Woolcock Institute of Medical Research Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06567210
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with an insomnia disorder, OR who score 10 or higher on a standard insomnia questionnaire (called the Insomnia Severity Index), AND who also score 10 or higher on a standard anxiety questionnaire (called the GAD-7).
  • People of any sex or gender.
  • People aged between 18 and 45 years old.
  • People who are able to give their informed agreement to take part in the study.
  • People who are proficient in English.

Who may not be able to join:

  • People who have a sleep or body-clock disorder other than insomnia — for example, excessive daytime sleepiness, restless limb movements during sleep, advanced or delayed sleep patterns, or moderate to severe sleep apnoea (confirmed by a previous sleep study showing certain measurements above set thresholds).
  • People with a current or past neurological condition, such as a stroke or brain injury.
  • People with a current or past diagnosis of bipolar disorder, psychosis, or moderate to severe obsessive-compulsive disorder (OCD).
  • People with a current uncontrolled mental health condition (other than major depression or anxiety disorders) that requires specialist care.
  • People taking medications that act on the brain, or who have a medical condition that could affect their ability to participate (confirm with trial site).
  • People who are pregnant, actively trying to conceive, or currently breastfeeding.
  • People who do shift work (working between 9pm and 6am) for two or more shifts per week over the past three months.
  • People who have travelled across time zones with more than a three-hour difference in the past 30 days — though a waiting period of one day per hour of time zone difference may apply (confirm with trial site).
  • People who are not willing to be informed about unexpected health findings that may come up during the study.
  • People who are unable or unwilling to give consent or follow the study instructions for any part of the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rick Wassing, PhD, Woolcock Institute of Medical Research

Phone: +61 0298502663

Australian sites

Woolcock Institute of Medical Research, Macquarie Park, New South Wales
0298502663

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Woolcock Institute of Medical Research
Registry
ClinicalTrials.gov
Start date
6 January 2026
Est. completion
1 June 2029

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

General Anxiety Disorder-7 (GAD-7) score; Anxiety Disorder diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov